Advantage Alpha Capital Partners LP Cuts Stake in Option Care Health, Inc. $OPCH

Advantage Alpha Capital Partners LP cut its stake in Option Care Health, Inc. (NASDAQ:OPCH) by 47.8% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 112,111 shares of the company’s stock after selling 102,508 shares during the quarter. Advantage Alpha Capital Partners LP owned approximately 0.07% of Option Care Health worth $3,641,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of OPCH. Durable Capital Partners LP acquired a new position in shares of Option Care Health during the first quarter valued at approximately $122,905,000. Nuveen LLC purchased a new stake in shares of Option Care Health during the first quarter worth approximately $70,965,000. Jennison Associates LLC increased its position in shares of Option Care Health by 145.6% during the second quarter. Jennison Associates LLC now owns 2,138,248 shares of the company’s stock worth $69,450,000 after purchasing an additional 1,267,660 shares in the last quarter. Fuller & Thaler Asset Management Inc. raised its stake in Option Care Health by 30.8% in the 1st quarter. Fuller & Thaler Asset Management Inc. now owns 4,204,481 shares of the company’s stock valued at $146,947,000 after purchasing an additional 989,048 shares during the last quarter. Finally, Boston Partners purchased a new position in Option Care Health in the 1st quarter valued at $24,353,000. 98.05% of the stock is currently owned by institutional investors and hedge funds.

Option Care Health Trading Down 0.6%

Shares of OPCH opened at $31.02 on Friday. The company has a current ratio of 1.52, a quick ratio of 1.00 and a debt-to-equity ratio of 0.81. Option Care Health, Inc. has a 12-month low of $22.29 and a 12-month high of $35.53. The firm has a 50-day moving average price of $27.93 and a 200 day moving average price of $29.43. The firm has a market capitalization of $4.92 billion, a P/E ratio of 24.82, a P/E/G ratio of 1.74 and a beta of 0.88.

Analyst Ratings Changes

A number of equities research analysts have recently issued reports on the stock. JMP Securities set a $36.00 target price on shares of Option Care Health in a report on Friday, October 31st. TD Cowen lowered their price target on shares of Option Care Health from $30.00 to $27.00 and set a “hold” rating on the stock in a research report on Monday, November 3rd. Wall Street Zen cut shares of Option Care Health from a “buy” rating to a “hold” rating in a research note on Saturday, November 15th. Barrington Research reissued an “outperform” rating and issued a $38.00 target price on shares of Option Care Health in a research note on Friday, October 31st. Finally, Morgan Stanley initiated coverage on Option Care Health in a report on Friday, October 17th. They set an “overweight” rating and a $35.00 target price on the stock. Nine analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $35.67.

Insider Activity

In other news, Director Norman L. Wright purchased 3,411 shares of the company’s stock in a transaction dated Tuesday, September 9th. The stock was acquired at an average price of $29.31 per share, with a total value of $99,976.41. Following the purchase, the director directly owned 15,501 shares in the company, valued at approximately $454,334.31. This represents a 28.21% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Harry M. Jansen Kraemer, Jr. purchased 38,000 shares of the business’s stock in a transaction dated Monday, November 3rd. The shares were purchased at an average price of $25.98 per share, with a total value of $987,240.00. Following the acquisition, the director directly owned 413,390 shares in the company, valued at approximately $10,739,872.20. The trade was a 10.12% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Insiders own 0.64% of the company’s stock.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.